Sintilimab combined with axitinib in the treatment of advanced chromophobe renal cell carcinoma: a case report

Chromophobe renal cell carcinoma (ChRCC) is a rare pathological type of renal cell carcinoma (RCC). Related systematic studies involving large numbers of patients are lacking, and more importantly, there is currently no international consensus on post-line treatment guidelines for ChRCC. The rapid d...

Descripció completa

Dades bibliogràfiques

Autors principals:	Huimin Zhang, Xiaofeng Cong, Chen Chen, Ziling Liu
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2024-02-01
Col·lecció:	Frontiers in Oncology
Matèries:	chromophobe renal cell carcinoma sintilimab axitinib second-line treatment long survival
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1325999/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!